The Food & Drug Administration and the American Society of Clinical Oncology will continue discussing the implications of Risk Evaluation & Mitigation Strategies for cancer therapies during an upcoming workshop.
FDA Office of Oncology Director Richard Pazdur disclosed plans for the upcoming workshop during the Institute of Medicine's National Cancer...





